HUYA Inc. Provides Update on Share Repurchase Program GUANGZHOU, China, March 21, 2025 /PRNewswire/ — HUYA Inc. ("Huya" or the… CISION PRNewswireMarch 21, 2025
Syneron Bio Announces Strategic Collaboration with AstraZeneca BEIJING, March 21, 2025 /PRNewswire/ — Syneron Bio, a cutting-edge oral macrocyclic peptide… CISION PRNewswireMarch 21, 2025
Pop Culture Group Co., Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency XIAMEN, China, March 21, 2025 /PRNewswire/ — Pop Culture Group Co., Ltd… CISION PRNewswireMarch 21, 2025
Press Release4BY4 to Showcase AI Video Solution 'PIXELL' at NAB 2025 with 8K Association SEOUL, South Korea, March 21, 2025 /PRNewswire/ — 4BY4, a leading AI-driven… CISION PRNewswireMarch 21, 2025
Press ReleaseCLOU's BESS Tour: Empowering Renewable Latin America SANTIAGO, Chile, March 21, 2025 /PRNewswire/ — The Energy Year Summit Chile… CISION PRNewswireMarch 21, 2025
Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ — Antengene Corporation Limited ("Antengene",… CISION PRNewswireMarch 21, 2025
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ — Harbour BioMed… CISION PRNewswireMarch 21, 2025
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b… CISION PRNewswireMarch 21, 2025
